<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Cat's whiskers (Orthosiphon stamineus) is commonly used as Java tea to treat <z:hpo ids='HP_0000787'>kidney stones</z:hpo> including a variety of <z:mpath ids='MPATH_177'>angiogenesis</z:mpath>-dependent diseases such as tumorous <z:hpo ids='HP_0000969'>edema</z:hpo>, <z:e sem="disease" ids="C0035435" disease_type="Disease or Syndrome" abbrv="">rheumatism</z:e>, diabetic <z:hpo ids='HP_0000618'>blindness</z:hpo>, and <z:hpo ids='HP_0001513'>obesity</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>In the present study, antitumor potential of standardized 50% <z:chebi fb="37" ids="16236,44730">ethanol</z:chebi> extract of O. stamineus leaves (EOS) was evaluated against <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumor</z:e> in athymic mice and antiangiogenic efficacy of EOS was investigated in human umbilical vein endothelial cells (HUVEC) </plain></SENT>
<SENT sid="2" pm="."><plain>EOS at 100 mg/kg caused 47.62 ± 6.4% suppression in <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumor growth</z:e>, while at 200 mg/kg it caused 83.39 ± 4.1% <z:mp ids='MP_0010537'>tumor regression</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumor</z:e> histology revealed significant reduction in extent of vascularization </plain></SENT>
<SENT sid="4" pm="."><plain>Enzyme-linked immunosorbent assay showed EOS (200 mg/kg) significantly reduced the vascular endothelial growth factor (VEGF) level in vitro (211 ± 0.26 pg/ml cell lysate) as well as in vivo (90.9 ± 2 pg/g tissue homogenate) when compared to the control (378 ± 5 and 135.5 ± 4 pg, respectively) </plain></SENT>
<SENT sid="5" pm="."><plain>However, EOS was found to be noncytotoxic to <z:hpo ids='HP_0003003'>colon cancer</z:hpo> and endothelial cells </plain></SENT>
<SENT sid="6" pm="."><plain>In vitro, EOS significantly inhibited the migration and tube formation of human umbilical vein endothelial cells (HUVECs) </plain></SENT>
<SENT sid="7" pm="."><plain>EOS suppressed VEGF-induced phosphorylation of VEGF receptor-2 in HUVECs </plain></SENT>
<SENT sid="8" pm="."><plain>High performance liquid chromatography (HPLC) analysis of EOS showed high <z:chebi fb="0" ids="17226">rosmarinic acid</z:chebi> contents, whereas phytochemical analysis revealed high protein and phenolic contents </plain></SENT>
<SENT sid="9" pm="."><plain>These results demonstrated that the antitumor activity of EOS may be due to its VEGF-targeted antiangiogenicity </plain></SENT>
</text></document>